Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study

AIMS: A number of intervention studies have shown that therapy with angiotensin receptor blockers, such as irbesartan, can improve metabolic parameters and reduce the incidence of diabetes mellitus. It is unknown whether this observation also holds true in routine clinical settings. METHODS: We eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Parhofer, Klaus G, Münzel, Felix, Krekler, Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211461/
https://www.ncbi.nlm.nih.gov/pubmed/18042288
http://dx.doi.org/10.1186/1475-2840-6-36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2211461/
https://www.ncbi.nlm.nih.gov/pubmed/18042288
http://dx.doi.org/10.1186/1475-2840-6-36

Ejemplares similares